Tumor Immunotherapy
Publish Year: 1395
نوع سند: مقاله کنفرانسی
زبان: English
View: 645
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
MPHBS01_148
تاریخ نمایه سازی: 22 آبان 1395
Abstract:
Using from different methods of Immunotherapy, is a sort of new method of cure. Immunotherapy or using immune response is considered as one of the most important and effective complementary approaches in cancer therapy after surgery, chemotherapy and radiotherapy. In recent years many clinical trials have investigated this approach. One approach for cancer immunotherapy, is based on the classification of components used in immunotherapy including cellular immunotherapy (DC, T cell and NK cell), monoclonal antibody, cytokine therapy, vaccines, and DNA-mediated immunotherapy using viruses and bacteria. Immunotherapy has a lot of advantages, but it is really expensive and complex process. This method needs accuracy and proficiency in science because of some problems such as the exact determination amount of used dosage in different patients. New findings indicate that, combination of immune therapies and chemotherapy could be more effective in cancer treatment. In this article we will focus on cancer Immunotherapy methods.© 2016 Published by CASRP publishing company Ltd. UK
Keywords:
Authors
Fatemeh Dehghani
BSc Student of Laboratory Sciences, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
Milad Shahhosseini
BSc Student of Laboratory Sciences, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
Ali Ghanbari
BSc Student of Laboratory Sciences, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
Mahmoud Keyghobadi
BSc Student of Laboratory Sciences, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran